197 related articles for article (PubMed ID: 2805287)
1. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Valantine HA; Wiederhold V; Stinson EB
Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
[TBL] [Abstract][Full Text] [Related]
2. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
Addonizio LJ; Hsu DT; Douglas JF; Kichuk MR; Michler RE; Quaegebeur JM; Smith CR; Rose EA
Circulation; 1993 Nov; 88(5 Pt 2):II224-9. PubMed ID: 8222158
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
4. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.
Olivari MT; Homans DC; Wilson RF; Kubo SH; Ring WS
Circulation; 1989 Nov; 80(5 Pt 2):III111-5. PubMed ID: 2805289
[TBL] [Abstract][Full Text] [Related]
5. Hyperlipidemia after clinical heart transplantation.
Taylor DO; Thompson JA; Hastillo A; Barnhart G; Rider S; Lower RR; Hess ML
J Heart Transplant; 1989; 8(3):209-13; discussion 219-20. PubMed ID: 2661770
[TBL] [Abstract][Full Text] [Related]
6. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
7. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
Taylor DO; Bristow MR; O'Connell JB; Price GD; Hammond EH; Doty DB; Karwande SV; Gay WA; Jones KW; Lappé D; Renlund DG
J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation.
Keogh A; Macdonald P; Mundy J; Chang V; Harvison A; Spratt P
J Heart Lung Transplant; 1992; 11(3 Pt 1):550-5; discussion 556. PubMed ID: 1610863
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
[TBL] [Abstract][Full Text] [Related]
10. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation.
Butman SM; Wild JC; Nolan PE; Fagan TC; Finley PR; Hicks MJ; Mackie MJ; Copeland JG
J Heart Lung Transplant; 1991; 10(3):351-8. PubMed ID: 1854763
[TBL] [Abstract][Full Text] [Related]
13. Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation.
Park JW; Merz M; Braun P; Vermeltfoort M
J Heart Lung Transplant; 1996 Jun; 15(6):572-9. PubMed ID: 8803754
[TBL] [Abstract][Full Text] [Related]
14. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis.
Gao SZ; Schroeder JS; Hunt SA; Valantine HA; Hill IR; Stinson EB
J Heart Lung Transplant; 1993; 12(6 Pt 1):1029-35. PubMed ID: 8312304
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
16. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
17. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
Opelz G
Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
[TBL] [Abstract][Full Text] [Related]
18. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
